Symposium: Inauguration Symposium for Theranostics Trial Center
May 5 @ 08:30 - 16:15
Inauguration Symposium for Theranostics Trial Center – bringing together national and international experts in the field of onco-theranostics.
The upcoming symposium will bring together national and international experts in the field of onco-theranostics, including pre-clinical and translational researchers, nuclear medicine specialists, oncologists, radiologists, medical physicists and representatives of Swedish pharmaceutical companies, patient organizations and decision-makers. Topics include advancements in targeting substances for diagnostic and therapeutic purposes, dosimetry, whole-body PET, and clinical applications. See the program below
The symposium is free of charge. Register to secure your attendance and submit abstract for poster session.
Target audience: Scientists, researchers, clinicians, policymakers, regulatory agents, patient representatives, students
Purpose: to provide a current state-of-the-art, inspiring future glimpse of new developments in the field of radiopharmaceuticals and showcase activities within the TTC.
Preliminary program
From 8.30 Coffee, registration
9.00-9.15 Welcome
Rimma Axelsson, Professor Nuclear Medicine, Founder of TTC
Mathias Axelsson, Head of Medical Diagnostics Karolinska University Hospital
Lars Holmgren, Professor and Head of Department of Oncology-Pathology
9.20-10.00 State-of-the-art overview of theranostics: use in clinical practice and ongoing trials
Désirée Deandreis, Professor, chief of the nuclear medicine division at Gustave Roussy and University of Turin, France
10.00-10.30 Coffee and posters
10.30-11.00 Development of protein-based theranostic pairs from an industrial perspective
Fredrik Frejd, Professor Uppsala University and CSO Affibody AB Sweden.
11.00-11.15 Theranostic trials in pediatric oncology
Jakob Stenman, Associate professor Karolinska Institutet and Pediatric surgeon at Karolinska University Hospital, Stockholm, Sweden
11.15 -11.30 Starting early-stage clinical trials with radiopharmaceuticals
Renske Altena, Associate professor, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
11.30-12.30 Lunch and posters
12.30-13.00 Physicist perspective – dosimetry of new radiotheranostic products
Caroline Stokke, Professor and Head of Nuclear Medicine & PET Physics, Oslo University Hospital, Norway
13.00- 13.30 At-221 and beyond
Stig Palm, Associate professor, Department of Radiation Physics, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden
13.30-14.00 Advances and future perspectives of 161-Tb-labelled radiopharmaceuticals.
Christina Müller, Professor Paul Scherrer Institute, Center for Radiopharmaceutical Sciences, Switzerland
14.00-14.30 Coffee and poster
14.30-15.15 New possibilities with whole body PET-cameras
Adrienne H Brouwers, Professor Department of Nuclear Medicine & Molecular Imaging, University Medical Center Groningen, The Netherlands
15.15-16.00 Panel Discussion
16.00-16.15 Concluding Remarks and Poster Prize
The organization committee consists of Rimma Axelsson, Cecilia Hindorf, Antonios Tzortzakakis and Thuy Tran.
Welcome!